Federated Hermes Inc. trimmed its stake in CRH plc (NYSE:CRH - Free Report) by 13.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,197,403 shares of the construction company's stock after selling 189,586 shares during the quarter. Federated Hermes Inc. owned approximately 0.18% of CRH worth $110,784,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of CRH. Heck Capital Advisors LLC purchased a new stake in CRH in the fourth quarter worth $32,000. Brown Brothers Harriman & Co. boosted its position in CRH by 214.3% during the fourth quarter. Brown Brothers Harriman & Co. now owns 352 shares of the construction company's stock worth $33,000 after purchasing an additional 240 shares during the period. Whipplewood Advisors LLC bought a new position in CRH during the fourth quarter worth about $38,000. Deseret Mutual Benefit Administrators raised its position in shares of CRH by 87.7% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 505 shares of the construction company's stock valued at $47,000 after purchasing an additional 236 shares during the period. Finally, Spire Wealth Management bought a new position in shares of CRH in the fourth quarter worth $57,000. 62.50% of the stock is owned by institutional investors.
Analysts Set New Price Targets
CRH has been the subject of a number of recent analyst reports. StockNews.com raised CRH from a "hold" rating to a "buy" rating in a report on Thursday, February 27th. Berenberg Bank set a $120.00 price target on shares of CRH in a report on Friday, February 28th. Citigroup decreased their price target on shares of CRH from $120.00 to $115.00 and set a "buy" rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. reduced their target price on CRH from $118.00 to $114.00 and set an "overweight" rating for the company in a research report on Tuesday, March 11th. Finally, Loop Capital initiated coverage on CRH in a report on Wednesday. They issued a "buy" rating and a $114.00 price target on the stock. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $110.00.
Get Our Latest Report on CRH
CRH Trading Up 0.6 %
Shares of NYSE:CRH traded up $0.53 on Friday, reaching $83.79. 2,447,747 shares of the company traded hands, compared to its average volume of 5,606,369. The stock has a market capitalization of $56.67 billion, a P/E ratio of 16.71, a price-to-earnings-growth ratio of 1.15 and a beta of 1.30. The business's 50-day simple moving average is $96.68 and its 200 day simple moving average is $96.29. CRH plc has a 52 week low of $71.18 and a 52 week high of $110.97.
CRH Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 16th. Shareholders of record on Friday, March 14th will be paid a $0.37 dividend. This is a boost from CRH's previous quarterly dividend of $0.23. This represents a $1.48 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date of this dividend is Friday, March 14th. CRH's payout ratio is 22.66%.
CRH Profile
(
Free Report)
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services.
Further Reading

Before you consider CRH, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CRH wasn't on the list.
While CRH currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.